Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $95.36 | $22.92 | 316.10% | 207.30x | 159.81x | 12.95x | 16.05x | 1.47x | $119.79M | 1.20% | $637.99M | 6.11 | $10.14B | -1,476.54 | ||
| LQDA | LIQUIDIA CORP | $86.22 | $16.73 | 415.24% | 359.25x | 25.95x | 26.34x | 70.62x | 1.77x | $41.15M | 0.54% | $108.58M | 1.23 | $7.63B | 142.36 | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $8.32 | $2.68 | 210.69% | 118.86x | 74.15x | 4.51x | 110.40x | 1.14x | $47.52M | 3.35% | $13.01M | 0.08 | $1.58B | 29.63 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $271.77 | $90.15 | 201.47% | 62.33x | 36.17x | 8.42x | 33.74x | 1.27x | $641.34M | 1.78% | $1.08B | 8.09 | $37.54B | 40.61 | ||
| HALO | HALOZYME THERAPEUTICS INC | $81.93 | $67.67 | 21.07% | 27.68x | 9.87x | 6.42x | 44.25x | 0.49x | $667.65M | 6.90% | $219.64M | 1.86 | $11.55B | 18.52 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $62.84 | $16.44 | 282.31% | 64.12x | 49.22x | 6.38x | 7.98x | 1.74x | $164.23M | 3.42% | $605.69M | 7.92 | $4.65B | 41.74 | ||
| KRYS | KRYSTAL BIOTECH INC | $335.19 | $90.16 | 271.76% | 43.25x | 43.20x | 23.53x | 7.74x | 2.08x | $237.38M | 2.42% | $1.28B | 43.59 | $9.39B | 43.88 | ||
| ADMA | ADMA BIOLOGICS INC | $8.27 | $8.73 | -5.29% | 11.99x | 9.86x | 3.83x | 4.91x | 0.50x | $107.90M | 5.53% | $390.33M | 1.65 | $1.98B | 8.92 | ||
| RPRX | ROYALTY PHARMA PLC | $58.83 | $38.54 | 52.64% | 30.80x | 10.96x | 10.53x | 3.41x | 0.65x | $2.34B | 9.11% | $9.94B | 22.75 | $42.25B | 36.31 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $59.33 | $37.17 | 59.64% | 42.38x | 16.06x | 3.52x | 1.85x | 0.63x | $767.06M | 6.72% | $6.21B | 32.27 | $9.83B | 20.36 | ||
| VCEL | VERICEL CORP | $45.05 | $8.67 | 419.61% | 104.77x | 93.45x | 7.83x | 6.46x | 2.20x | $47.49M | 2.08% | $356.23M | 7.02 | $2.29B | 56.56 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $300.53 | $93.35 | 221.95% | 38.04x | 32.82x | 21.77x | 6.04x | 1.78x | $122.22M | 2.05% | $997.32M | 50.16 | $6.36B | 28.20 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $253.87 | $46.72 | 443.41% | 540.15x | 9.80x | 3.54x | 3.51x | 1.82x | $1.30B | 8.26% | $4.53B | 73.22 | $19.49B | 28.87 | ||
| ASND | ASCENDIS PHARMA A | $253.86 | $76.25 | 232.95% | 26.91x | 17.45x | 15.48x | 27.47x | 2.78x | $52.94M | 0.34% | $574.09M | 9.24 | $16.15B | 173.17 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $35.32 | $33.85 | 4.33% | 13.96x | 9.39x | 2.27x | 2.25x | 0.53x | $341.79M | 16.74% | $910.35M | 15.75 | $1.61B | 6.81 | ||
| TECH | BIO-TECHNE CORP | $71.60 | $15.89 | 350.47% | 100.85x | 34.32x | 9.24x | 5.38x | 1.85x | $269.60M | 2.41% | $2.09B | 13.34 | $11.29B | 44.11 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.19 | $8.52 | -86.03% | 4.41x | -4.02x | 1.11x | 1.30x | 0.05x | $7.24M | 10.59% | $52.93M | 0.92 | $15.25M | 0.98 | ||
| TGTX | TG THERAPEUTICS INC | $56.04 | $20.67 | 171.06% | 17.40x | 39.71x | 11.56x | 14.71x | 3.91x | -$14.19M | -0.17% | $583.13M | 4.04 | $8.89B | 59.24 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $477.36 | $158.30 | 201.56% | 28.06x | 24.69x | 9.93x | 6.26x | 2.08x | $3.71B | 3.06% | $19.36B | 76.20 | $117.65B | 21.81 | ||
| EXEL | EXELIXIS INC | $55.37 | $29.51 | 87.65% | 17.75x | 16.99x | 6.02x | 7.19x | 1.27x | $917.69M | 6.42% | $1.94B | 7.49 | $13.86B | 13.13 | ||
| UTHR | UNITED THERAPEUTICS CORP | $528.47 | $227.77 | 132.01% | 18.05x | 19.36x | 7.25x | 3.80x | 2.07x | $1.02B | 4.42% | $5.90B | 135.66 | $21.15B | 12.34 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.21 | $2.02 | 59.19% | 13.38x | 13.78x | 1.97x | 3.11x | 1.25x | $4.11M | 1.59% | $82.33M | 1.03 | $191.69M | 9.02 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $656.01 | $412.23 | 59.14% | 15.41x | 14.03x | 4.57x | 2.19x | 1.05x | $4.11B | 6.03% | $31.42B | 302.15 | $68.52B | 11.93 | ||
| VCYT | VERACYTE INC | $56.61 | $8.56 | 561.66% | 51.00x | 51.05x | 8.31x | 3.36x | 6.01x | $155.34M | 3.45% | $1.34B | 16.90 | $4.29B | 37.30 | ||
| INCY | INCYTE CORP | $117.67 | $62.57 | 88.05% | 16.14x | 14.77x | 4.38x | 4.18x | 1.44x | $1.45B | 6.19% | $5.62B | 28.21 | $20.08B | 10.73 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.